DK0700300T3 - Oprensning af plasmaproteiner - Google Patents

Oprensning af plasmaproteiner

Info

Publication number
DK0700300T3
DK0700300T3 DK94915731T DK94915731T DK0700300T3 DK 0700300 T3 DK0700300 T3 DK 0700300T3 DK 94915731 T DK94915731 T DK 94915731T DK 94915731 T DK94915731 T DK 94915731T DK 0700300 T3 DK0700300 T3 DK 0700300T3
Authority
DK
Denmark
Prior art keywords
pct
aqueous phase
detergent
sec
salt
Prior art date
Application number
DK94915731T
Other languages
Danish (da)
English (en)
Inventor
Sven Isaksson
Stefan Winge
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Application granted granted Critical
Publication of DK0700300T3 publication Critical patent/DK0700300T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
DK94915731T 1993-05-07 1994-05-06 Oprensning af plasmaproteiner DK0700300T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
PCT/SE1994/000422 WO1994026287A1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins

Publications (1)

Publication Number Publication Date
DK0700300T3 true DK0700300T3 (da) 2001-12-31

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915731T DK0700300T3 (da) 1993-05-07 1994-05-06 Oprensning af plasmaproteiner

Country Status (15)

Country Link
US (1) US5817765A (no)
EP (1) EP0700300B1 (no)
JP (1) JP3771935B2 (no)
AT (1) ATE205719T1 (no)
AU (1) AU677332B2 (no)
CA (1) CA2161804C (no)
DE (1) DE69428356T2 (no)
DK (1) DK0700300T3 (no)
ES (1) ES2164702T3 (no)
FI (1) FI113779B (no)
NO (1) NO313084B1 (no)
NZ (1) NZ266234A (no)
PT (1) PT700300E (no)
SE (1) SE9301582D0 (no)
WO (1) WO1994026287A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
EP1250929A4 (en) * 1999-12-20 2004-12-29 Mitsubishi Pharma Corp BY POROUS MEMBRANE-TREATED, VIRUS-FREE PLASMA PROTEIN COMPOUND AND ITS MANUFACTURING PROCESS
RS20060077A (en) * 2003-08-12 2008-08-07 Octapharma Ag., Process for preparing an alpha-1-antitrypsin solution
NZ552680A (en) * 2004-06-29 2010-03-26 Reliance Life Sciences Pvt Ltd Process for the preparation of virus-safe biological fluids
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
WO2010033913A1 (en) * 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
EP2350271B1 (en) 2008-11-20 2016-01-27 Biogen MA Inc. Arginine inactivation of enveloped viruses
JP2013523143A (ja) * 2010-04-08 2013-06-17 キアゲン ゲーエムベーハー 核酸を単離および精製するための方法
EP2395082A1 (en) 2010-06-14 2011-12-14 QIAGEN GmbH Extraction of nucleic acids from wax-embedded samples
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
KR102125695B1 (ko) * 2012-10-03 2020-06-24 체에스엘 베링 아게 단백질 정제 방법
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
EP4013445A4 (en) * 2019-09-20 2023-09-27 Plasma Technologies, LLC THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
FI113779B (fi) 2004-06-15
JP3771935B2 (ja) 2006-05-10
CA2161804A1 (en) 1994-11-24
ATE205719T1 (de) 2001-10-15
NZ266234A (en) 1996-06-25
PT700300E (pt) 2002-03-28
DE69428356D1 (de) 2001-10-25
AU6763494A (en) 1994-12-12
ES2164702T3 (es) 2002-03-01
DE69428356T2 (de) 2002-04-25
EP0700300A1 (en) 1996-03-13
EP0700300B1 (en) 2001-09-19
AU677332B2 (en) 1997-04-17
JPH08509746A (ja) 1996-10-15
NO313084B1 (no) 2002-08-12
CA2161804C (en) 2003-12-02
NO954428L (no) 1995-11-06
WO1994026287A1 (en) 1994-11-24
FI955306A0 (fi) 1995-11-06
FI955306A (fi) 1995-11-06
SE9301582D0 (sv) 1993-05-07
NO954428D0 (no) 1995-11-06
US5817765A (en) 1998-10-06

Similar Documents

Publication Publication Date Title
DK0700300T3 (da) Oprensning af plasmaproteiner
DK0707594T3 (da) Adskillelse af proteiner
NO20031471L (no) Glykoformer av faktor VII
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
DK0691982T3 (da) Separering af proteiner
EE9700200A (et) Bis-aminohappe hüdroksüetüülamino-sulfoonamiidsed retroviirusliku proteaasi inhibiitorid
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
DE69512416D1 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
ATE346088T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protease-domäne ns3 und ns4a aus dem hepatitis c virus enthalten, und damit bereitgestellte kristalle
RU2003117016A (ru) Способ получения латентного антитромбина iii
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DK0567448T3 (da) Fremgangsmåde til fremstilling af faktor VIII
DE59610319D1 (de) Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
ATE434036T1 (de) Filtrationsverfahren zur trennung von viren
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
FI1343809T4 (fi) Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
DE69928282D1 (de) Substituierte 1,3,5-triazine als herbizide
NO994821L (no) Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale
DE69802636T2 (de) Verbessertes Verfahren zur Herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidinverbindungen
ATE199556T1 (de) Verfahren zur fraktionierung von deacylierten glycerophospholipiden
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
DE59611353D1 (de) Transketolase-verwandtes protein
DE60214587D1 (de) Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose
ATE256655T1 (de) Neue aminsäure-derivate, verfahren zur ihrer herstellung, ihre zusammensetzungen und ihre verwendung als sonnenfilter
ATE162523T1 (de) Wasserchathrate von piperazinylpyridin